Multi-omics alleviates the limitations of panel-sequencing for cancer drug response prediction Permalink
Published in bioRxiv, 2022
Recommended citation: Baranovskii, A., Gunduz, I. B., Franke, V., Uyar, B., & Akalin, A. (2022). Multi-omics alleviates the limitations of panel-sequencing for cancer drug response prediction. BioRxiv, 2022.06.15.496249. doi:10.1101/2022.06.15.496249 https://www.biorxiv.org/content/10.1101/2022.06.15.496249v1
